[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Bioinvestor24 @bioinvestor24 on x 3682 followers
Created: 2025-07-25 20:39:56 UTC
@badinvestor99 @Matthew_ABCD I am not interested in MASH now. And I understand FDA position. And I agree AKRO is small phase X and benefit will drop in phase X. But MDGl will likely acquire GLp1 to survive long term. That is the right thing to do
XX engagements
